Top

Scientific Programme - Advanced Programme


FRIDAY OCTOBER 30
08.00 Welcome and introduction
R. de Franchis (Milan)
08.10 Lecture 1:
New concept of risk stratification
Speaker: J. Abraldes (Edmonton)
08.30 Lecture 2:
Clinical stages and ordinal outcomes in portal hypertension
Speaker: G. D’Amico
08.50 Lecture 3:
Life style and genetic modifiers of progression of Compensated Advanced Chronic Liver Disease (cACLD)
Speaker: A. Berzigotti (Bern)
09.15Linea
13.00		 Session 1
EVALUATION AND RISK STRATIFICATION
09.15 PART 1: HVPG as a gold standard
Chairpersons: J.C. Garcia-Pagàn (Barcelona), Z. Haskal (Charlotteville)
H. Ferral (Evanston), R. Gaba (Chicago), F. Schepis (Modena)
10.00 Coffee break and poster viewing
10.30 PART 2: Non-invasive surrogates for cACLD, CSPH, Varices
Chairpersons: A. Berzigotti (Bern), J. Genescà (Barcelona) Panelists: J.G. Abraldes (Edmonton), S. Augustin (Barcelona),
J. Fallowfield (Edinburgh), M. Thiele (Odense)
13.00 Lunch break
14.00Linea
18.20		 Session 2
NEW SCENARIOS
14.00 PART 1: Progression and regression of cirrhosis
Chairs: W. Laleman, D. Patch
14.00 PELS in progression. Can they regress?
Speaker: I. Wanless (Halifax)
14.20 Fibrogenesis and regression of fibrosis
Speaker: M. Pinzani (London)
14.40 Angiogenesis and progression of ACLD
Speaker: V. Shah (Rochester)
15.00 Drugs to modify liver fibrosis progression and regression (preclinical and clinical studies)
Speaker: J. Gracia (Barcelona)
15.20 PART 2: Impact of etiological therapy for cirrhosis
Chairpersons: M. Mandorfer (Vienna), E. Tsochatzis (London) Panelists: S. Francque (Antwerp), J. Jia (Beijing),
S. Lens (Barcelona), H. Yoshiji (Kashihara
16.40 Coffee break
17.10 PART 3: Impact of non-etiological novel therapies in cirrhosis
Chairpersons: A. Albillos (Madrid), J. Trebicka (Frankfurt) Panelists: J. Bajaj (Richmond), J. Gracia (Barcelona),
A. Krag (Odense), W. Laleman (Leuven), V. Shah (Rochester)
18.20Linea
19.30		 Session 3
CLINICAL SETTINGS
18.20 PART 1: Preventing decompensation: review of current evidence
Chairpersons: J. Bosch (Bern), C. Ripoll (Halle)
Panelists: R. Bañares (Madrid), V. Calvaruso (Palermo),
A. Dell’Era (Milan), S. Gomes Rodrigues (Bern),
D. Tripathi (Birmingham), C. Villanueva (Barcelona)
SATURDAY OCTOBER 31
07.30Linea
8.30		 Industry Sponsored Breakfast Symposium
SATURDAY OCTOBER 31
Baveno VII Workshop (continued)
08.40Linea
13.40		 Session 3
CLINICAL SETTINGS(CONTINUED)
08.40 PART 2: Acute variceal bleeding
Chairpersons: V. Hernandez-Gea (Barcelona), D. Thabut (Paris) Panelists: A. Càrdenas (Barcelona), A. Escorsell (Barcelona),
G. Han (Xi’an), X. Luo (Chengdu), D. Patch (London),
B. Procopet (Cluj-Napoca), M. Rudler (Paris)
10.40 Coffee break and poster viewing
11.10 PART 3: Preventing further decompensation
Chairpersons: G. Garcia-Tsao (New Haven), T. Reiberger (Vienna) Panelists: C. Bureau (Toulouse), G. D’Amico (Palermo),
V. La Mura (Milan), S. Piano (Padua),
P. Tandon (Edmonton), L. Turco (Modena)
13.40 Lunch break
14.40Linea
17.40		 Session 4
VASCULAR LIVER DISORDERS
14.40 PART 1: Splanchnic Vein thrombosis
Chairpersons: S. Sarin (New Delhi), D. Valla (Clichy)
Panelists: A. Baiges (Barcelona), M. Barrufet (Barcelona),
J.J. Kiladjian (Paris), A. Plessier (Clichy),
M. Primignani (Milan), F. Turon (Barcelona)
16.10 PART 2: Other issues in vascular liver disorders
Chairpersons: A. De Gottardi (Lugano), P.E. Rautou (Paris)
Panelists: S. Murad (Rotterdam), V. Paradis (Clichy),
M. Senzolo (Padua), L. Tellez (Madrid)
17.40 Closing remarks
R. de Franchis

ORGANIZING SECRETARIAT


Logo ADB
Via S. Felice, 6
40122 Bologna, Italy
Ph. +39 051 0959160
Fax +39 051 0959164
info@adbcongressi.it
www.adbcongressi.it
info@baveno7.com - www.baveno7.com
BAVENO VII WORKSHOP
NEW POSTPONEMENT
TO 2021

BAVENO VII WORKSHOP POSTPONED TO 2021


Due to the persistence of the state of emergency related to the Covid 19 pandemic and to the uncertainties around what the situation will be in October 2020, The Baveno VII Steering Committee has regretfully taken the unavoidable decision to postpone the Workshop.
Therefore, the Baveno VII Consensus Conference will no longer take place on October 30-31, 2020 but will be postponed to 2021.
The Steering Committee is currently considering the possible options for the postponement to 2021 and updated information will be published as soon as possible.
We thank you for your understanding and your support and look forward to meeting you in 2021.